Radium-223 injectable prostate cancer therapy has gained FDA approval as “Xofigo” Bayer Pharmaceutical announced. 05/16/13
Webinar Registration
Radium-223 Gets FDA Approval
Radium-223 injectable prostate cancer therapy has gained FDA approval as “Xofigo” Bayer Pharmaceutical announced. 05/16/13
Webinar Registration